Nature Medicine

Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. The journal seeks to publish research papers that demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results. Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. As with other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was 25.430, making it the highest-cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.

Publisher
Nature Publishing Group
History
1995--present
Website
http://www.nature.com/nm/index.html
Impact factor
25.430 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Autism spectrum disorders

AI-enhanced precision medicine identifies novel autism subtype

A novel precision medicine approach enhanced by artificial intelligence (AI) has laid the groundwork for what could be the first biomedical screening and intervention tool for a subtype of autism, reports a new study from ...

Autism spectrum disorders

Cannabis use in pregnancy linked to a greater risk of autism

In the largest study of its kind, Ottawa researchers found that children whose mothers reported using cannabis during pregnancy were at greater risk of autism. The incidence of autism was 4 per 1000 person-years among children ...

Diseases, Conditions, Syndromes

Ancient part of immune system may underpin severe COVID-19

One of the immune system's oldest branches, called complement, may be influencing the severity of COVID-19 disease, according to a new study from researchers at Columbia University Irving Medical Center.

page 1 from 49